(Q54359506)

English

Inhibition of colony formation of drug-resistant human tumor cell lines by combinations of interleukin-2-activated killer cells and antitumor drugs.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

Inhibition of colony formation of drug-resistant human tumor cell lines by combinations of interleukin-2-activated killer cells and antitumor drugs. (English)

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

0 references

author name string

A Ohtsu

1

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

Y Sasaki

2

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

T Tamura

3

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

Y Fujiwara

4

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

Y Ohe

5

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

K Minato

6

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

K Nakagawa

7

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

M Bungo

8

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

N Saijo

9

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

publication date

1 March 1989

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Japanese Journal of Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

80

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

3

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

265-270

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917724

28 May 2018

Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917724

28 May 2018

Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917724

28 May 2018

Enhancement of murine lymphoma cell lysability by CTL and by LAK cells, after treatments with mitomycin C and with adriamycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917724

28 May 2018

Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917724

28 May 2018

Primary Bioassay of Human Tumor Stem Cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917724

28 May 2018

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917724

28 May 2018

Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin-2 activated killer cells and by activated monocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917724

28 May 2018

Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917724

28 May 2018

In vitro growth inhibition of cisplatin-resistant human lung cancer cell lines by recombinant human tumor necrosis factor and/or recombinant human interferon-gamma by virtue of collateral sensitivity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917724

28 May 2018

Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917724

28 May 2018

Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917724

13 August 2018

Separation of leukocytes from blood and bone marrow. Introduction

1 reference

https://pubmed.ncbi.nlm.nih.gov/2498260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of cytotoxicity of freshly obtained lymphocytes and of lymphocytes activated with recombinant interleukin II (rIL-2) against lung cancer cell lines by human tumor clonogenic assay (HTCA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/2498260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis by activated lymphocytes of melanoma and small cell lung cancer cells surviving in vitro treatment with mafosfamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/2498260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor cell lipid composition and sensitivity to humoral immune killing. II. Influence of plasma membrane and intracellular lipid and fatty acid content

1 reference

https://pubmed.ncbi.nlm.nih.gov/2498260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1349-7006.1989.TB02303.X

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

28 May 2018

http://europepmc.org/abstract/PMC/5917724

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54359506&oldid=1770153221"